Frequently Asked Questions
The growth rate of the insomnia market is 5.4%.
Therapy type, drug class, route of administration, end-users and distribution channel are the factors on which the insomnia market research is based.
North America dominates the insomnia market and will flourish its dominance over the forecast period because of global leaders in research and development activities.
Major companies in the insomnia market are Takeda Pharmaceutical Company Limited., Dr. Reddy’s Laboratories Ltd., Pfizer Inc., Endo International plc, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Mylan N.V., Novartis AG, Lupin., Cipla Inc., Aurobindo Pharma., Torrent Pharmaceuticals Ltd, Alvogen., Merck Sharp & Dohme Corp., Apotex Inc., Zydus Cadila., Saneca Pharmaceuticals, Unichem Laboratories, Neuland Laboratories Ltd., Divi's Laboratories Limited and HIKAL Ltd.
Rising stress levels, the presence of patented molecules in the market, potential drugs in the clinical pipeline, the introduction of technologically advanced medical devices, and the growing geriatric population are the growth drivers of the insomnia market.
